abstract gray background

Archives: Resources

PPD | e-book
Modernize chronic disease trials through digital transformation

Wearables, remote monitoring and decentralized trial models can reduce patient burden, support engagement and capture meaningful data in chronic disease trials.

View the e-book
PPD | Report
Meeting Pregnancy and Lactation Safety Requirements: A Guide for Sponsors

Build a more efficient, compliant, and patient-centered approach to pregnancy and lactation safety studies with expert-backed strategies in this practical guide.

Read the report
PPD | Overview
Optimizing your oncology endpoint data collection

Explore key considerations for improving oncology endpoint data collection across imaging, eCOA, connected devices and cardiac safety.

Read the overview
PPD | Case Study
Moving beyond paper: eCOA successfully delivered across three Phase I oncology studies

Discover how at-home eCOA supported participant compliance, data quality and early oncology trial insights across three Phase I studies.

Read More
PPD | Overview
Regulatory guidance for PRO strategy in oncology trials

Explore regulatory considerations for incorporating patient-reported outcomes into oncology trials to support patient-centered evidence.

Read the overview
PPD | Case Study
Standardized imaging and ECG data in Alzheimer’s trials

Discover how standardized MRI, PET and ECG data collection supported evidence generation in a complex global Alzheimer’s disease study.

Read More
PPD | infographic
Optimize cardiac safety in clinical trials with centralized ECG

Explore how centralized ECG data collection improves consistency, safety oversight and regulatory readiness in clinical trials.

View the infographic
PPD | Webinar
Maximizing value in early phase oncology trials

Discover how innovative endpoints in early phase oncology trials support earlier insights across efficacy, safety and patient experience.

Read More
PPD | Webinar
Holistic endpoint strategies for obesity trials

Explore how diverse endpoint strategies allow sponsors to assess safety, efficacy and broader health impacts in obesity and GLP-1 trials.

Read More